Concepedia

Anna Forsythe

AF

Statistics

Publications

22

Citations

728

H-Index

16

Active since

2010

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Centre for Biomedical Network Research on Rare Diseases

Universitat Autònoma de Barcelona

Health Outcomes Solutions (United States)

Anna Forsythe is an author at Novartis (United States) specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

2010–2023

22

Publications

22

Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy

N. Lawrence Edwards, John S. Sundy, Anna Forsythe et al. · Journal of Medical Economics · 2010 · 96 citations · Full text

, , +13

Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials

Vibeke Strand, Dinesh Khanna, Jasvinder A. Singh et al. · The Journal of Rheumatology · 2012 · 73 citations · Full text

, , +16

Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

Javier Cortés, Stacie Hudgens, Chris Twelves et al. · Breast Cancer Research and Treatment · 2015 · 73 citations · Full text

, , +12

A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy

C.S. Kwon, Patrick Daniele, Anna Forsythe et al. · Journal of health economics and outcomes research · 2021 · 59 citations · Full text

, , +17

A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy

C.S. Kwon, Patrick Daniele, Anna Forsythe et al. · Journal of health economics and outcomes research · 2021 · 47 citations · Full text

, , +17

1–5 of 22